Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Short sleep duration is associated with the development of impaired fasting glucose : the Western New York health study

Tools
- Tools
+ Tools

Rafalson, Lisa, Donahue, Richard P., Stranges, Saverio, LaMonte, Michael J., Dmochowski, Jacek, Dorn, Joan M. and Trevisan, Maurizio. (2010) Short sleep duration is associated with the development of impaired fasting glucose : the Western New York health study. Annals of Epidemiology, Vol.20 (No.12). pp. 883-889. ISSN 1047-2797

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.annepidem.2010.05.002

Abstract

PURPOSE: To examine whether sleep duration was associated with incident-impaired fasting glucose (IFG) over 6 years of follow-up in the Western New York Health Study. METHODS: Participants (N = 1,455, 68% response rate) who were free of type 2 diabetes and known cardiovascular disease at baseline (1996-2001) were reexamined in the period 2003-2004. A nested case-control study was conducted. Cases had fasting plasma glucose (FPG) less than 100 mg/dL at baseline and 100 to 125 mg/dL at follow-up: controls (n = 272) had FPG less than 100 mg/dL at both exams. Cases (n = 91) were individually matched to three controls (n 272) on sex, race, and year of study enrollment. Average sleep duration was categorized as short ( < 6 hours), mid-range (6 to 8 hours), and long ( > 8 hours). RESULTS: In multivariate conditional logistic regression after adjustment for several diabetes risk factors, the odds ratio (OR) of IFG among short sleepers was 3.0 (95% confidence limit [CL]: 1.05, 8.59) compared to mid-range sleepers. There was no association between long sleep and IFG: OR 1.6 (95% CL: 0.45, 5.42). Adjustment for insulin resistance attenuated the association only among short sleepers: OR 2.5 (95% CL: 0.83, 7.46). CONCLUSIONS: Short sleep duration was associated with an elevated risk of IFG. Insulin resistance appears to mediate this association. Ann Epidemiol 2010;20:883-889. (C) 2010 Elsevier Inc. All rights reserved.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Glucose -- Metabolism, Glucose -- Physiological effect, Case-control method, Sleep, Sleep disorders
Journal or Publication Title: Annals of Epidemiology
Publisher: Elsevier Science Inc.
ISSN: 1047-2797
Date: December 2010
Volume: Vol.20
Number: No.12
Number of Pages: 7
Page Range: pp. 883-889
Identification Number: 10.1016/j.annepidem.2010.05.002
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: National Institutes of Health (U.S.) (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (NIDDK)
Grant number: RO1 DK60587 (NIDDK)
References: 1. Penev PD. Sleep deprivation and energy metabolism: to sleep, perchance to eat? Curr Opin Endocrinol Diabetes Obes. 2007;14:374–381. 2. National Sleep Foundation ‘‘Sleep in America’’ Poll. Washington (DC): National Sleep Foundation; 2005. 3. Krueger PM, Friedman EM. Sleep duration in the United States: a crosssectional population-based study. Am J Epidemiol. 2009;169:1052–1063. 4. Broman JE, Lundh LG, Hetta J. Insufficient sleep in the general population. Neurophysiologie Clinique. 1996;26:30–39. 5. Kristen L. Knutson EVC. Associations between Sleep Loss and Increased Risk of Obesity and Diabetes. Ann New York Acad Sci. 2008;1129:287–304. 6. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. [see comment 47:816–817]. Hypertension. 2006;47:833–839. 7. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163:205–209. Comment in: Arch Intern Med 2003;168:1374. 8. Kripke DF, Simons RN, Garfinkel L, Hammond EC. Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry. 1979;36:103–116. 9. Ferrie JE, Shipley MJ, Cappuccio FP, Brunner E, Miller MA, Kumari M, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. [see comment 30:1614–1615]. Sleep. 2007;30:1659–1666. 10. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29:657–661. 11. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26:380–384. 12. Chaput JP, Despres JP, Bouchard C, Tremblay A. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia. 2007;50:2298–2304. 13. Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005;165:863–867. 14. Trevisan M, Dorn J, Falkner K, Russell M, Ram M, Muti P, et al. Drinking pattern and risk of non-fatal myocardial infarction: a population-based case-control study. [see comment 99:276–277]. Addiction. 2004;99:313–322. 15. Dorn JM, Hovey K, Muti P, Freudenheim JL, Russell M, Nochajski TH, et al. Alcohol drinking patterns differentially affect central adiposity as measured by abdominal height in women and men. J Nutr. 2003;133: 2655–2662. 16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572. Erratum in: JAMA. 2003;290:197. 17. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol. 1985;121:91–106. 18. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. 19. Mathews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. 20. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141:846–850. 21. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20:865–870. 22. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–1439. 23. Havel P, Taborsky GJ. Stress-induced activation of the neuroendocrine system and the effects on carbohydrate metabolism. In: Porte DJ, Sherwin RS, Baron A, eds. Ellenberg & Rifkin’s diabetes mellitus. 6th ed. Philadelphia: McGraw Hill; 2003, p 127. 24. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166:1756–1762. 25. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43:678–683. 26. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53: 693–700. 27. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, Pradhan AD, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. [see comment 286:2233]. JAMA. 2001;286:327–334. 28. Stranges S, Dorn JM, Shipley MJ, Kandala NB, Trevisan M, Miller MA, et al. Correlates of short and long sleep duration: a cross-cultural comparison between the United Kingdom and the United States: the Whitehall II Study and the Western New York Health Study.Am J Epidemiol. 2008;168: 1353–1364. 29. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19: 838–845. 30. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197.
URI: http://wrap.warwick.ac.uk/id/eprint/4764

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us